Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Eur J Med Chem ; 208: 112829, 2020 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-33002736

RESUMEN

ß-Lactam antibiotics are one of the most relevant drug classes of antibacterial agents worldwide. The discovery and the market of first ß-lactam antibiotic (Penicillin G) is a symbolic landmark of modern chemotherapy. Since then, several other ß-lactam antibiotics have been introduced in the therapy, revolutionizing the treatment of bacterial infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial resistance. Among the resistance mechanisms, the expression of ß-lactamase enzymes is one of the most studied and prevalent. The combined use of beta-lactamase inhibitors with broad spectrum activity ß-lactam antibiotics has been an effective strategy to circumvent the resistance issue. This review discusses, with a focus on structural aspects, the different classes of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams and penems) in light of their stability, sensitivity to ß-lactamases, mechanism of action and spectrum of antimicrobial activity. ß-Lactamase inhibitors (structurally correlated and non-correlated to the ß-lactam system) and their proposed inhibition mechanisms are also discussed.


Asunto(s)
Antibacterianos/química , Inhibidores de beta-Lactamasas/química , beta-Lactamas/química , Animales , Antibacterianos/metabolismo , Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Infecciones Bacterianas/tratamiento farmacológico , Química Farmacéutica , Humanos , Hidrólisis , Modelos Químicos , Estructura Molecular , Inhibidores de beta-Lactamasas/metabolismo , Inhibidores de beta-Lactamasas/uso terapéutico , beta-Lactamasas/metabolismo , beta-Lactamas/metabolismo , beta-Lactamas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...